ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1756

Exosomal Cargo and Surface Markers: Informative Signals in Axial Spondyloarthritis

Fataneh Tavasolian1, star lively2, chiara Pastrello3, Melissa Lim1, Addison Pacheco4, Zoya Qaiyum5, Michael Tang4, Zeynep Baskurt3, Igor Jurisica6, Mohit Kapoor5 and Robert Inman4, 1University of Toronto, Toronto, ON, Canada, 2University Heaklth Network, Toronto, 3University Health Network, Toronto, 4University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 6University Health Network, Toronto, Canada

Meeting: ACR Convergence 2025

Keywords: Ankylosing spondylitis (AS), Epigenetics, Non-coding RNA, TH17 Cells, Treg cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1752–1757)

Session Type: Abstract Session

Session Time: 11:00AM-11:15AM

Background/Purpose: Exosomes are small extracellular vesicles carrying surface molecules and molecular cargo, including microRNAs (miRNAs), that mediate intercellular communication. Both the exosomal cargo and surface markers are increasingly recognized as key players in immune modulation and potential biomarkers in autoimmune diseases. In ankylosing spondylitis (AS), their role remains underexplored. We conducted an integrated investigation of exosomal surface markers, miRNA profiles, and their functional impact on regulatory T cells (Tregs) and purinergic signaling, aiming to identify new diagnostic and therapeutic avenues.

Methods: Plasma-derived exosomes were isolated from AS patients and healthy controls (HC). Exosomal surface markers were analyzed using flow cytometry, and miRNA sequencing was performed to profile cargo signatures. Functional effects were assessed in CD4+ T cells and Tregs by evaluating FOXP3+IRF4+ and FOXP3+IRF4+CTLA4+ subsets, proliferation assays, and CD39/CD73 enzymatic activity. DNA methylation of FOXP3, IL2R, and IRF4 was analyzed in four groups: HC Tregs, AS Tregs, HC Tregs exposed to AS exosomes, and CD4+CD25− controls. Gene expression profiling in sorted Tregs was used to assess key immune regulatory and apoptotic genes.

Results: Gene expression profiling of sorted Tregs from AS patients revealed downregulation of IKZF2/Helios, TNFα, CD95/FAS, BCLXL, and CD45RO, alongside upregulation of IGF1R, indicating disrupted transcriptional networks important for Treg survival and stability. DNA methylation analysis demonstrated hypermethylation of FOXP3, IL2R, and IRF4 in AS Tregs, with similar patterns observed in HC Tregs exposed to AS exosomes, highlighting the epigenetic reprogramming potential of exosomes. miRNA sequencing of AS plasma-derived exosomes identified upregulation of miR-30c-5p, a regulator targeting IRF4, directly linking exosomal cargo to impaired Treg function. Functionally, AS exosomes carrying miR-30c-5p led to decreased proliferation of CD4+ T cells and a marked reduction in FOXP3+IRF4+ and FOXP3+IRF4+CTLA4+ Treg subsets. In parallel, AS exosomes induced reduced CD39/CD73 surface expression and impaired ATPase activity, indicating defective extracellular adenosine production and weakened immunosuppressive signaling. Collectively, these results demonstrate that AS exosomes orchestrate immune dysregulation through parallel effects on Treg stability and purinergic signaling.

Conclusion: Our integrated study demonstrates that AS plasma-derived exosomes drive immune dysregulation through miRNA-mediated gene regulation, epigenetic remodeling, and impaired purinergic signaling, culminating in Treg instability and loss of immune tolerance. These findings highlight exosomal signatures as promising biomarkers and therapeutic targets to restore immune balance in AS.

Supporting image 1Figure 1- Exosome Isolation and Validation :(a) Exosome characteristics with morphology, size and markers. Exosomes display a round-shaped morphology in negative transmission electron microscopy (TEM). It is at 22 000× magnification, demonstrating the density of isolated exosomes in plasma (b) and are bilayer and spherical by cryo-TEM imaging. (c) Exosome sizes can be determined using nanoparticle tracking. Nanoparticle tracking analysis was used to examine the exosome size and concentration, and the results showed that the exosomes had an average size of 147 nm. (d) Expression of the exosomal markers CD63 and CD9 was confirmed with western blot.

Supporting image 2Figure 2: Immune Dysregulation and Exosome-Mediated Adenosine Modulation in axial spondyloarthritis (AS)

(A) Immune Dysregulation in AS: The enthesitis microenvironment (EME) in AS is characterized by cellular interactions that drive inflammation and pathological bone remodeling. Panel A depicts cellular interactions where IL-23 stimulates Th17 cells to produce IL-17 and TNF-α, recruiting macrophages and neutrophils to the entheses. The cytokine release amplifies inflammation, leading to tissue damage and fibrosis. Panel B illustrates the roles of fibroblasts, macrophages, and T cells in the dysregulated cytokine signaling cascade. IL-17 and TNF-α receptor activation stimulate fibroblasts to release RANKL and MMP, driving osteoclast activity and disrupting bone homeostasis. Concurrently, osteoblast activation leads to pathological bone formation (syndesmophytes), highlighting the imbalance in bone remodeling. Panel C demonstrates genetic dysregulation in AS, with HLA-B27 misfolding inducing ER stress, promoting IL-23 production, and driving Th17-mediated inflammation. Panel D emphasizes cytokine-driven bone remodeling, showing osteoclast-mediated bone resorption and osteoblast-driven syndesmophyte formation under persistent inflammation.

(B) Exosome-Mediated Adenosine Modulation of Inflammation and Bone Dynamics in AS: Exosomes released from immune and stromal cells deliver enzymes (CD39/CD73) and miRNAs (e.g., miR-146a, miR-29b) to modulate immune responses and bone remodeling in AS. CD39/CD73-mediated adenosine production suppresses osteoclast activity and enhances osteoblast activity via A2A receptor signaling. While adenosine reduces RANKL and MMP expression in fibroblasts and promotes M2 macrophage polarization, the reduced CD39/CD73 expression observed in AS limits adenosine availability, impairing its anti-inflammatory and bone-regulating effects. The balance between osteoclast-mediated bone erosion and osteoblast-mediated syndesmophyte formation is critical to AS pathology. Arrows indicate cellular interactions and regulatory pathways modulated by adenosine and exosomal components.

Supporting image 3

Figure 3. DNA Methylation Analysis. A: Hypermethylation of FOXP3 in AS Treg cells compared to HC. B: Hypermethylation of IL2R in AS Treg cells, contrasting with the typical demethylation observed in Tregs. C & D: Hypermethylation of IRF4 in Treg cells may impair their function in AS. This alteration may impact Treg function. HC Treg cells exposed to AS exosomes exhibited similar methylation patterns to AS Treg cells in all figures, highlighting the role of AS exosomes in Treg dysfunction.


Disclosures: F. Tavasolian: None; s. lively: None; c. Pastrello: None; M. Lim: None; A. Pacheco: None; Z. Qaiyum: None; M. Tang: None; Z. Baskurt: None; I. Jurisica: None; M. Kapoor: None; R. Inman: AbbVie/Abbott, 2, Janssen, 2, Novartis, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Tavasolian F, lively s, Pastrello c, Lim M, Pacheco A, Qaiyum Z, Tang M, Baskurt Z, Jurisica I, Kapoor M, Inman R. Exosomal Cargo and Surface Markers: Informative Signals in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/exosomal-cargo-and-surface-markers-informative-signals-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exosomal-cargo-and-surface-markers-informative-signals-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology